← Back to Screener
Bio Green Med Solution, Inc. 6% Convertible Preferred Stock (BGMSP)
Price$1.15
Favorite Metrics
Price vs S&P 500 (26W)-88.28%
Price vs S&P 500 (4W)2.21%
Market Capitalization$6.54M
All Metrics
Book Value / Share (Quarterly)$1.27
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.88
Price vs S&P 500 (YTD)-33.19%
Gross Margin (TTM)18.47%
Net Profit Margin (TTM)-214.06%
EPS (TTM)$-1.86
10-Day Avg Trading Volume0.23M
EPS Excl Extra (TTM)$-1.86
EPS (Annual)$-1.37
Dividend / Share (Annual)$0.02
ROI (Annual)-43.82%
Gross Margin (Annual)18.47%
Net Profit Margin (5Y Avg)-7621.91%
Cash / Share (Quarterly)$0.65
Revenue Growth QoQ (YoY)710.00%
ROA (Last FY)-36.63%
Revenue Growth TTM (YoY)1637.21%
EBITD / Share (TTM)$-1.97
ROE (5Y Avg)-788.35%
Operating Margin (TTM)-277.64%
Cash Flow / Share (Annual)$-0.88
P/B Ratio0.96x
P/B Ratio (Quarterly)1.06x
Net Interest Coverage (TTM)-284.57x
ROA (TTM)-48.99%
EPS Incl Extra (Annual)$-1.37
Current Ratio (Annual)4.70x
Quick Ratio (Quarterly)3.66x
3-Month Avg Trading Volume0.10M
52-Week Price Return-97.98%
P/S Ratio (Annual)8.76x
Asset Turnover (Annual)0.09x
52-Week High$100.80
Operating Margin (5Y Avg)-8498.71%
EPS Excl Extra (Annual)$-1.37
26-Week Price Return-79.53%
Quick Ratio (Annual)3.66x
13-Week Price Return-26.57%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.70x
Enterprise Value$3.036
Asset Turnover (TTM)0.09x
Inventory Turnover (Annual)1.67x
Pretax Margin (Annual)-400.40%
Cash / Share (Annual)$0.65
3-Month Return Std Dev99.51%
Gross Margin (5Y Avg)62.05%
ROE (Last FY)-43.82%
Net Interest Coverage (Annual)-110.66x
EPS Basic Excl Extra (Annual)$-1.37
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.86
ROI (TTM)-58.13%
Dividend Growth Rate (5Y)-39.23%
P/S Ratio (TTM)8.76x
Pretax Margin (5Y Avg)-8353.92%
Revenue / Share (Annual)$0.34
Price vs S&P 500 (52W)-133.07%
Year-to-Date Return-29.05%
5-Day Price Return1.94%
EPS Normalized (Annual)$-1.37
ROA (5Y Avg)-137.62%
Net Profit Margin (Annual)-401.34%
Month-to-Date Return5.00%
EBITD / Share (Annual)$-1.43
Operating Margin (Annual)-465.86%
ROI (5Y Avg)-788.35%
EPS Basic Excl Extra (TTM)$-1.86
P/B Ratio (Annual)1.06x
Dividend / Share (TTM)$0.02
Inventory Turnover (TTM)3.39x
Pretax Margin (TTM)-213.39%
Book Value / Share (Annual)$1.27
Price vs S&P 500 (13W)-29.44%
Dividend Yield (TTM)0.93%
Beta-0.40x
Revenue / Share (TTM)$0.34
ROE (TTM)-58.13%
52-Week Low$0.73
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
BGMSPBio Green Med Solution, Inc. 6% Convertible Preferred Stock | 8.76x | 1637.21% | 18.47% | — | $1.15 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company developing targeted cancer therapeutics focused on cell cycle inhibition. The company's pipeline includes CDK and PLK inhibitors, with fadraciclib and plogosertib among its lead programs. Headquartered in the United Kingdom, the company is advancing these programs through clinical development.